Can Chatbot Artificial Intelligence Replace Infectious Diseases Physicians in the Management of Bloodstream Infections? A Prospective Cohort Study
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: The development of chatbot artificial intelligence (AI) has raised major questions about their use in healthcare. We assessed the quality and safety of the management suggested by Chat Generative Pre-training Transformer 4 (ChatGPT-4) in real-life practice for patients with positive blood cultures. Methods: Over a 4-week period in a tertiary care hospital, data from consecutive infectious diseases (ID) consultations for a first positive blood culture were prospectively provided to ChatGPT-4. Data were requested to propose a comprehensive management plan (suspected/confirmed diagnosis, workup, antibiotic therapy, source control, follow-up). We compared the management plan suggested by ChatGPT-4 with the plan suggested by ID consultants based on literature and guidelines. Comparisons were performed by 2 ID physicians not involved in patient management. Results: Forty-four cases with a first episode of positive blood culture were included. ChatGPT-4 provided detailed and well-written responses in all cases. AI’s diagnoses were identical to those of the consultant in 26 (59%) cases. Suggested diagnostic workups were satisfactory (ie, no missing important diagnostic tests) in 35 (80%) cases; empirical antimicrobial therapies were adequate in 28 (64%) cases and harmful in 1 (2%). Source control plans were inadequate in 4 (9%) cases. Definitive antibiotic therapies were optimal in 16 (36%) patients and harmful in 2 (5%). Overall, management plans were considered optimal in only 1 patient, as satisfactory in 17 (39%), and as harmful in 7 (16%). Conclusions: The use of ChatGPT-4 without consultant input remains hazardous when seeking expert medical advice in 2023, especially for severe IDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
Ayers, J. W., Poliak, A., Dredze, M., Leas, E. C., Zhu, Z., Kelley, J. B., Faix, D. J., Goodman, A. M., Longhurst, C. A., Hogarth, M., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.1838 · Cited by 2,613
Gilson, A., Safranek, C. W., Huang, T., Socrates, V., Chi, L., Taylor, R. A., & Chartash, D. (2023) · JMIR Medical Education · doi:10.2196/45312 · Cited by 2,078
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
Lee, P., Bubeck, S., & Petro, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmsr2214184 · Cited by 1,738
Artificial Intelligence and Machine Learning in Clinical Medicine, 2023
Haug, C. J., & Drazen, J. M. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2302038 · Cited by 1,215
The new antibiotic mantra-“shorter is better”.
Spellberg, B. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3646 · Cited by 291
ChatGPT and antimicrobial advice: the end of the consulting infection doctor?
Howard, A., Hope, W., & Gerada, A. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00113-5 · Cited by 202
Li, R., Kumar, A., & Chen, J. H. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.1835 · Cited by 104
Cited by
Tam, T. Y. C., Sivarajkumar, S., Kapoor, S., Stolyar, A. V., Polanska, K., McCarthy, K. R., Osterhoudt, H., Wu, X., Visweswaran, S., Fu, S., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01258-7 · Cited by 424
Large Language Models for Chatbot Health Advice Studies: A Systematic Review
Huo, B., Boyle, A., Marfo, N., Tangamornsuksan, W., Steen, J. P., McKechnie, T., Lee, Y., Mayol, J., Antoniou, S. A., Thirunavukarasu, A. J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.57879 · Cited by 283
Omar, M., Brin, D., Glicksberg, B., & Klang, E. (2024) · American Journal of Infection Control · doi:10.1016/j.ajic.2024.03.016 · Cited by 59
Metadata
- Authors
- Maillard, A., Micheli, G., Lefevre, L., Guyonnet, C., Poyart, C., Canouï, E., Belan, M., & Charlier, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-10-12
- Volume
- 78
- Issue
- 4
- Pages
- 825-832
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4387564414
- Cited by
- 64
- References
- 8
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.